Jazz Pharmaceuticals
JAZZ
JAZZ
375 hedge funds and large institutions have $9.64B invested in Jazz Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 120 increasing their positions, 103 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
375
Holders Change
+52
Holders Change %
+16.1%
% of All Funds
8.6%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.23%
New
91
Increased
120
Reduced
103
Closed
35
Calls
$117M
Puts
$58.7M
Net Calls
+$58.5M
Net Calls Change
+$60.6M
Top Buyers
| 1 |
BlackRock
New York
|
+$294M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$123M |
| 3 |
State Street
Boston,
Massachusetts
|
+$91.1M |
| 4 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$87.3M |
| 5 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
+$78.3M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$391M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$83.8M |
| 3 |
SIG
Senator Investment Group
New York
|
-$80.7M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$55M |
| 5 |
Goldman Sachs
New York
|
-$44.7M |
